Back to 
Ensign Peak Advisors, Inc
Ensign Peak Advisors, Inc
SABS2 quarters
Position history for Ensign Peak Advisors, Inc's holdings in SAB BIOTHERAPEUTICS INC
Yes. Ensign Peak Advisors holds 1,172,641 shares of SABS (Sab Biotherapeutics), worth $4.6M, as of its Q2 2026 13F filing. It reduced the position by 202,969 shares (-14.8%) from Q1 2026. Ensign Peak Advisors has held SABS since Q1 2026, across 2 quarterly 13F filings.
Current Value
$4.6M
Current Shares
1.2M
Total Value Change
-$695,286
Total Shares Change
-202,969
Quarter-by-Quarter History
Other major holders of SABS: ADAGE CAPITAL PARTNERS GP, L.L.C., RA CAPITAL MANAGEMENT, L.P., BALYASNY ASSET MANAGEMENT L.P.